Pharmaceutical group
Theratechnologies
A group of 3 companies with 7 medicines in 4 countries.
Group structure
3 companies in 2 countries
Canada1
United States1
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
7 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| EGRIFTA1mg base/vial | 2mg base/vial ยท Powder | Tesamorelin | United States | Marketed | 2010 |
| Egrifta WR11.6mg ยท For Injection | Tesamorelin | United States | Marketed | 2025 |
| TROGARZO150mg/ml ยท Injectable | Ibalizumab | United States | Marketed | 2018 |
| EGRIFTA2 mg / vial ยท Kit, Powder For Solution | Tesamorelin | Canada | Cancelled | |
| EGRIFTA1 mg / vial ยท Kit, Powder For Solution | Tesamorelin | Canada | Cancelled | 2015 |
| Trogarzo | Ibalizumab | EU (EMA) | Withdrawn | 2019 |
| TROGARZO 200 mg CONCENTRADO PARA SOLUCION PARA PERFUSION200 mg ยท Concentrado para soluciรณn para perfusiรณn | Ibalizumab | Spain | Withdrawn | 2021 |



